Jayson Bedford
Stock Analyst at Raymond James
(3.84)
# 689
Out of 4,479 analysts
199
Total ratings
53.55%
Success rate
6.5%
Average return
Main Sectors:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN AxoGen | Initiates: Outperform | $13 | $7.52 | +72.87% | 1 | Jul 1, 2024 | |
| ICUI ICU Medical | Upgrades: Outperform | $135 | $117.53 | +14.86% | 10 | Jun 17, 2024 | |
| PODD Insulet | Maintains: Outperform | $218 → $213 | $197.19 | +8.02% | 14 | May 10, 2024 | |
| DXCM DexCom | Maintains: Strong Buy | $151 → $160 | $112.49 | +42.23% | 20 | Apr 26, 2024 | |
| BSX Boston Scientific | Maintains: Strong Buy | $73 → $85 | $76.55 | +11.04% | 15 | Apr 25, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $84 → $89 | $86.50 | +2.89% | 16 | Jan 30, 2024 | |
| ABT Abbott Laboratories | Maintains: Outperform | $124 → $127 | $103.20 | +23.06% | 21 | Jan 25, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $372 → $435 | $438.81 | -0.87% | 6 | Jan 25, 2024 | |
| ANGO AngioDynamics | Maintains: Outperform | $12 → $10 | $5.66 | +76.68% | 8 | Jan 9, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $133 → $137 | $106.27 | +28.92% | 4 | Jan 3, 2024 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $172 → $175 | $146.03 | +19.84% | 16 | Jan 3, 2024 | |
| BDX Becton, Dickinson and Company | Maintains: Outperform | $269 → $275 | $229.24 | +19.96% | 2 | Jan 3, 2024 | |
| TFX Teleflex | Maintains: Outperform | $227 → $271 | $211.25 | +28.28% | 12 | Dec 20, 2023 | |
| BWAY BrainsWay | Downgrades: Market Perform | n/a | $5.92 | - | 7 | Nov 16, 2023 | |
| MASI Masimo | Downgrades: Market Perform | n/a | $113.42 | - | 4 | Nov 8, 2023 | |
| TNDM Tandem Diabetes Care | Downgrades: Market Perform | n/a | $39.15 | - | 9 | Apr 24, 2023 | |
| EW Edwards Lifesciences | Downgrades: Market Perform | n/a | $91.23 | - | 13 | Feb 6, 2023 | |
| BAX Baxter International | Downgrades: Market Perform | n/a | $32.85 | - | 6 | Jan 5, 2023 | |
| MDT Medtronic | Downgrades: Market Perform | n/a | $77.37 | - | 8 | Aug 24, 2022 | |
| SENS Senseonics Holdings | Downgrades: Underperform | n/a | $0.39 | - | 2 | Mar 5, 2021 | |
| HOLX Hologic | Upgrades: Outperform | n/a | $73.53 | - | 1 | Jun 3, 2020 | |
| BEAT HeartBeam | Maintains: Outperform | n/a | $2.95 | - | 2 | Oct 31, 2018 | |
| IART Integra LifeSciences Holdings | Downgrades: Market Perform | n/a | $29.19 | - | 2 | Jan 2, 2018 |
AxoGen
Jul 1, 2024
Initiates: Outperform
Price Target: $13
Current: $7.52
Upside: +72.87%
ICU Medical
Jun 17, 2024
Upgrades: Outperform
Price Target: $135
Current: $117.53
Upside: +14.86%
Insulet
May 10, 2024
Maintains: Outperform
Price Target: $218 → $213
Current: $197.19
Upside: +8.02%
DexCom
Apr 26, 2024
Maintains: Strong Buy
Price Target: $151 → $160
Current: $112.49
Upside: +42.23%
Boston Scientific
Apr 25, 2024
Maintains: Strong Buy
Price Target: $73 → $85
Current: $76.55
Upside: +11.04%
Merit Medical Systems
Jan 30, 2024
Maintains: Outperform
Price Target: $84 → $89
Current: $86.50
Upside: +2.89%
Abbott Laboratories
Jan 25, 2024
Maintains: Outperform
Price Target: $124 → $127
Current: $103.20
Upside: +23.06%
Intuitive Surgical
Jan 25, 2024
Maintains: Outperform
Price Target: $372 → $435
Current: $438.81
Upside: -0.87%
AngioDynamics
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $5.66
Upside: +76.68%
Zimmer Biomet Holdings
Jan 3, 2024
Maintains: Outperform
Price Target: $133 → $137
Current: $106.27
Upside: +28.92%
Johnson & Johnson
Jan 3, 2024
Maintains: Outperform
Price Target: $172 → $175
Current: $146.03
Upside: +19.84%
Becton, Dickinson and Company
Jan 3, 2024
Maintains: Outperform
Price Target: $269 → $275
Current: $229.24
Upside: +19.96%
Teleflex
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $211.25
Upside: +28.28%
BrainsWay
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.92
Upside: -
Masimo
Nov 8, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $113.42
Upside: -
Tandem Diabetes Care
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $39.15
Upside: -
Edwards Lifesciences
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $91.23
Upside: -
Baxter International
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $32.85
Upside: -
Medtronic
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $77.37
Upside: -
Senseonics Holdings
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.39
Upside: -
Hologic
Jun 3, 2020
Upgrades: Outperform
Price Target: n/a
Current: $73.53
Upside: -
HeartBeam
Oct 31, 2018
Maintains: Outperform
Price Target: n/a
Current: $2.95
Upside: -
Integra LifeSciences Holdings
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $29.19
Upside: -